Kiniksa Pharmaceuticals International, plc KNSA
96.28 USD +0.52 (+0.54%)
At closeNov 13, 2026, 4:11 AM EST
96.95 +0.67 +0.70%
Pre-market · Nov 13, 4:11 AM ET
94.34 Day range 96.67
37.02 52-week range 99.31
- YTD
- +133.41%
- 1 year
- +138.97%
News
globenewswire.com Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London LONDON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Jefferies Global…
defenseworld.net AlphaCentric Advisors LLC Acquires New Position in Kiniksa Pharmaceuticals International, plc $KNSA AlphaCentric Advisors LLC bought a new position in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) during the undefined quarter, according to its most recent 13F filing with the…
benzinga.com JP Morgan Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $122 JP Morgan analyst Anupam Rama maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight and raises the price target from $107 to $122.
benzinga.com Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $101 Goldman Sachs analyst Paul Choi maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy and raises the price target from $90 to $101.
benzinga.com Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $102 Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperform and raises the price target from $99 to $102.- benzinga.com Wells Fargo Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $110 Wells Fargo analyst Yanan Zhu maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight and raises the price target from $87 to $110.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) shares rose 23.1% to $89.86 during Tuesday's regular session. The market value of their outstanding shares is at $5.6 billion. As per the press release,…
benzinga.com Crude Oil Moves Lower; Corning Earnings Top Views U.S. stocks mostly rose Tuesday: S&P 500 +0.5%, Nasdaq +1.1%, while Dow slipped. Oil fell 1.5%; Corning beat Q3 estimates.
benzinga.com Pentair, JetBlue Airways, Hawkins And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed as Dow slips 0.1%; Pentair jumps 9.8% on strong Q3 results and raised FY26 sales guidance, with several stocks rallying.
benzinga.com Kiniksa Pharmaceuticals Q3 2026 Earnings Call Transcript Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 14.6% to $3.3 during Tuesday's pre-market session. The company's market cap stands at $14.4 million. Pomdoctor (NASDAQ:POM) stock…
benzinga.com Kiniksa Pharmaceuticals Raises FY2026 Sales Guidance from $980.000M-$995.000M to $1.045B-$1.050B vs $996.102M Est Kiniksa Pharmaceuticals (NASDAQ:KNSA) raises FY2026 sales outlook from $980.000 million-$995.000 million to $1.045 billion-$1.050 billion vs $996.102 million estimate.- benzinga.com Kiniksa Pharmaceuticals Q3 EPS $0.56 Beats $0.37 Estimate, Sales $285.970M Beat $260.611M Estimate Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.37 by 51.35 percent. This is a 143.48 percent increase over…